Drugmaker pauses HPV Gardasil exports as rival Pfizer gets boost from better than expected Covid vaccine and pill sales ...

MSD has agreed to pay up to $610 million to acquire Caraway Therapeutics, a Cambridge, Massachusetts biotech focusing on neurodegenerative disorders and rare diseases. The big pharma, known as ...

Kelun-Biotech has become the second drugmaker to ... Daiichi's was re-filed for EGFR-positive NSCLC only. Outside China, MSD has rights to sac-TMT under the terms of a partnership signed in ...

and MSD Biotech in Dublin. In its most recent accounts filed with the Companies Registration Office, WuXi Biologics Ireland Ltd reported an operating loss of €71.6m for 2023. The company said ...

The regulatory agency will review MSD’s new drug application (NDA) for Welireg under a Priority Review, with a Prescription ...

Evaxion Biotech (EVAX) shares fell over 25% premarket on Thursday after the company priced an offering to raise $10.8M. The ...

SPONSOR PROFILE: About MSD Merck Sharp and Dohme (MSD) is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, MSD discovers, develops, ...

Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and ...

Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 ...